ADVERTISEMENT

Last updated: · 14 min read

In brief
Measles is the textbook contagious disease, yet estimates of its R0 run from about 5 to 18. The virus is the same; part of what changes is how people live and mix, on buses, at home and in classrooms. R0 says nothing about deadliness either. The 1918 flu killed at least 50 million people with a median R0 of just 1.8. SARS and COVID had similar R0s, yet only SARS was contained, because much of COVID’s spread happens before symptoms appear. A public that can read these numbers can argue about the choices behind them.

Measles is the textbook example of a contagious disease, with an R0 usually quoted as 12 to 18. Look at the estimates themselves, though, and the number refuses to sit still: one classic compilation of studies from different places and eras put it anywhere from about 5 to 18, and later reviews found an even wider spread. One infected person in a fully susceptible population might seed five others, or eighteen.

The virus is the same in every one of those estimates. Part of what differs is the society it moves through. If you absorbed R0 during the pandemic years the way most people did, as a fixed property stamped into the pathogen’s biology that the virus carries wherever it goes, the measles numbers are a problem.

Across different arrangements of people, the central parameter of epidemic dynamics varies more than threefold. Some of that difference comes from how crowded the buses and classrooms are, and none of it is written in the genome. The mathematics that describes this has existed for nearly a century, but it rarely reached the public in a usable form.

The shape of the curve

The modern mathematics of epidemics took shape in 1927, while mathematical biology was still a young field. Two Scottish scientists, W.O. Kermack and A.G. McKendrick, laid the conceptual foundation for almost everything that followed in infectious disease modeling, including the curves on television screens in 2020.

The SIR model divides a population into three compartments: Susceptible (those who can catch the disease), Infected (those who currently have it), and Recovered or Removed (those who can no longer transmit it). Two rates drive the dynamics. β is the transmission probability per contact multiplied by the average contact rate. γ is the rate at which infected people recover or are removed. The ratio β/γ in a fully susceptible population is R0.

When R0 is greater than 1, the epidemic grows. Each infected person generates more than one new case; the infected pool expands. But it doesn’t expand forever. The act of infecting people is also the act of removing them from the susceptible pool. As the fraction of susceptibles falls, so does the effective reproduction number, Rt: the actual average number of new infections per case at any given moment. When Rt drops to 1, the epidemic peaks. When Rt falls below 1, the epidemic declines.

This is why epidemic curves have the shape they do. The initial exponential rise, the peak and the eventual fall recur across pathogens and centuries. Real epidemics often come in several such waves, as 1918 did, when behavior shifts, seasons turn or the virus changes; but each wave follows the same arithmetic, because the same mathematical structure describes any pathogen spreading from person to person through a susceptible population.

Nor does the epidemic halt when Rt hits 1. It overshoots: momentum built up in the infected pool keeps generating new cases for some time after the trajectory has reversed. Left to run, the epidemic ends when the susceptible pool has been depleted far enough that sustained transmission becomes impossible, whether or not anything has defeated the pathogen. Interventions, interrupted exposure or plain chance can end an outbreak sooner, with most people still susceptible.

For a disease with an R0 of 2, the epidemic runs out of fuel after infecting roughly 80% of a fully susceptible population, if nothing intervenes. For an R0 of 3, the figure is approximately 94%.

The final-size equation

The SIR model's final attack rate satisfies z = 1 − e^(−R0·z), where z is the share of the population eventually infected. At R0 = 1.5, roughly 58% of the population is eventually infected. The calculation assumes that nobody starts out immune and that no intervention is sustained. The relationship is nonlinear: small increases in R0 at the lower end drive large increases in attack rate. This is why containing a pathogen with R0 just above 1 is feasible, while containing one with R0 of 5 without vaccination means cutting transmission by more than four-fifths, and why the herd immunity threshold, the proportion immune needed to drive Rt below 1, rises steeply with R0. The overshoot means the epidemic will always infect more people than the threshold alone would imply.

What R0 is made of

The SIR framework is one of the most influential models in all of biology. Its core logic of susceptibles, infections and removals is the starting point for virtually every serious quantitative analysis of infectious disease, from 1918 influenza to COVID-19.

ADVERTISEMENT

R0 can be decomposed as β × D: the transmission rate multiplied by the average duration of infectiousness. The transmission rate β is itself a product of two things: the probability that contact between an infected and susceptible person results in transmission, and the rate at which those contacts happen. The first part is largely biology, though masks and ventilation can lower it. The second, the contact rate, measures how often infected and susceptible individuals encounter one another, and it is a property of the society: how densely people live, how they use transit, how children are distributed across shared spaces.

Change the social structure and you change R0 directly, with no mutation required. Measles has been studied across more social environments than almost any other human pathogen, and the familiar “R0 of 12 to 18” comes from just two of them, early-20th-century America and post-war England and Wales; elsewhere, estimates run as low as about 5.

Part of that spread reflects how differently each study modelled the data; part reflects real differences in population density, household size, schooling and social mixing, which makes R0, in one review’s phrase, “a function of human social behavior and organization.” Because the values vary even more widely than the textbook 12 to 18, countries do better to estimate R0 from local data than to borrow the textbook figure.

When a public health intervention closes schools or recommends against indoor gatherings, it lowers the contact rate; masks on transit lower the chance that a given contact passes the virus on. The virus’s biology is unchanged; its effective R in that population falls, by a calculable amount. Calling that “fighting the virus” invites people to expect the pathogen’s defeat. What the intervention does is cap how many people the pathogen reaches, and it can do so only within limits and at a cost.

Four pandemics, one structure

The 1918 influenza pandemic killed at least 50 million people, possibly 100 million. It was the deadliest influenza pandemic on record, and the deadliest pandemic of the twentieth century. Its R0, though, was modest. An epidemic model fitted to death curves from 45 US cities found a median reproduction number below 3, and a median basic reproduction number below 4 even after allowing for prior immunity. Pooled, the published estimates put the median at just 1.8. That is below measles in any setting, and below what most readers assume for a catastrophe at that scale.

What made 1918 catastrophic was its case fatality rate, which was extraordinarily high, and strangely so in healthy young adults. Its age-mortality curve was W-shaped, which distinguishes 1918 from almost every other influenza pandemic: alongside the usual peaks in infants and the elderly sat a third peak in young adults, and nearly half of all influenza deaths fell in the 20-to-40 age band. That pattern is rare: in ordinary flu seasons almost all deaths occur among the elderly, while in 1918 mortality was greatest among the young.

R0 measures how many people each case infects. It says nothing about how quickly those infections follow one another, or about harm per case. An epidemic with modest transmissibility and a high case fatality rate can kill vastly more people than one with explosive transmissibility and low lethality. The two parameters are distinct, and need not move together. Conflating them, by assuming that catastrophic death tolls imply high R0 or that high R0 implies catastrophic death tolls, leaves people systematically unable to reason about epidemic risk.

The mystery of the W-curve

Why young adults died at elevated rates in 1918 remains contested. The leading hypotheses are not mutually exclusive. Original antigenic sin: immune systems shaped by earlier influenza strains may have mounted a cross-reactive response to the 1918 H1N1 virus that was more harmful than protective. Cytokine storm: the strong immune responses of healthy younger adults may have generated hyperinflammatory reactions causing more damage than the infection itself. Secondary bacterial pneumonia: without antibiotics, post-influenza pneumococcal infections were often fatal, and wartime crowding created ideal conditions for secondary infection. Geographic analyses complicate the picture further. In Madrid, young adults faced the highest standardized risk, yet there is little evidence of a true W-shaped excess-mortality curve there; the young-adult toll varied from place to place. Canadian and US records show a mortality peak at exactly age 28, which Gagnon and colleagues linked to early-life exposure to the 1889–90 "Russian flu", a form of immune imprinting.

The 1957 H2N2 and 1968 H3N2 pandemics each had R0 estimates well below measles. The 1968 pandemic killed about one million people worldwide, slightly fewer than 1957’s 1.1 million, with a comparable R0. The H3N2 strain kept the N2 neuraminidase of the H2N2 virus that had circulated since 1957, so the new virus was only half new to a population that had spent a decade meeting N2. In Europe and Asia most 1968-pandemic deaths were delayed until the second season; the researchers who documented that delay proposed that higher pre-existing N2 immunity, followed by a later drift in the neuraminidase, explains it. Estimates put the 1968 first-wave R0 at 1.06 to 2.06. In 1968 the susceptible pool was already smaller than the raw population figure suggested, shrunk by earlier exposure rather than by any intervention.

Then there are the two SARS viruses. SARS-CoV-1 had R0 estimates of 2 to 5. Estimates for the original SARS-CoV-2 strain clustered around 3. These values are close enough that R0 alone cannot explain why the SARS outbreak was contained worldwide in 2003 while COVID killed millions and became endemic.

The difference lies in the timing of peak viral shedding relative to symptom onset. In SARS-CoV-1, viral load peaks in the second week of illness, after severe symptoms develop — patients were already hospitalized before they were maximally contagious. In SARS-CoV-2, shedding begins during the incubation period and peaks around symptom onset or just before. In an outbreak at a Washington State nursing facility, testing found viable virus in specimens from 17 of 24 presymptomatic residents, some collected as early as six days before symptoms appeared. An accompanying editorial called this asymptomatic and presymptomatic spread the “Achilles’ heel” of COVID control: much of the transmission happens before the infected person knows they’re sick.

With similar R0, the two viruses had opposite containment outcomes, a difference the basic SIR model cannot see, because it doesn’t track when during an infection a person is most contagious.

ADVERTISEMENT

The evolving pathogen

The preceding sections treat the pathogen as fixed — a useful simplification for establishing the framework, but false as biology. The virus is evolving throughout the epidemic, under constant selection pressure, and that evolution is partly predictable, though its direction depends on conditions.

Popular science keeps repeating one simplification in particular, and as a general rule it fails: the idea that viruses inevitably evolve toward lower virulence over time, because killing your host is evolutionarily bad strategy.

Early in an epidemic, when the susceptible pool is large and transmission opportunities abundant, selection pressure on the pathogen strongly favors transmissibility. A strain that replicates explosively and reaches new hosts before it kills the current one can outcompete a milder strain, even at real cost to the host. Evolutionary biologists organize this theory around what they call the three Ts: trade-offs, transmission, and time scales. The direction of selection is conditional: it depends on where the epidemic sits in its trajectory, what transmission bottlenecks exist, how immunity shapes the available pool of hosts. The engine of that logic holds up well in experiments: faster within-host replication goes with both higher virulence and higher transmission. Because harm so often comes with spreading well, selection for transmissibility need not make a pathogen milder.

As an epidemic matures and susceptibles become scarcer, the calculus shifts. Strains that keep hosts mobile, still going to work and mixing indoors with others, may gain a transmission advantage over strains that incapacitate. Being less incapacitating need not make such strains less deadly.

COVID’s Omicron variant shows transmissibility and severity moving apart, though it cannot show that selection for mobile hosts was the cause. Pooled estimates gave a mean basic reproduction number for Omicron of 9.5, and studies that estimated both variants put its basic reproduction number at about 2.5 times Delta’s on average. Omicron caused fewer deaths per infection, particularly in populations with prior immunity from vaccination or earlier infection. But it spread fast enough that total hospitalizations and mortality remained substantial through the transition. Talk of the pandemic “winding down” as Omicron emerged mistook lower severity per infection for safety.

Extinction or equilibrium

A local epidemic can burn out while its pathogen circulates elsewhere, but in the long run a human pathogen meets one of two fates. Either it is eliminated from human populations, driven to extinction through immunity, intervention or the exhaustion of every viable host, or it becomes endemic: a lasting, often seasonal level of circulation sustained by the continuous replenishment of susceptible hosts through births, waning immunity, or immune-evasive evolution.

The herd immunity threshold (HIT) is 1 − 1/R0. At measles’s R0 of approximately 15, HIT ≈ 93%. This is why measles vaccination campaigns become vulnerable when coverage drops below 95%. Between 2018 and 2022, average first-dose coverage across EU/EEA countries fell from 95% to 92%. In 2023 EU/EEA countries reported nearly 2,400 measles cases, about three-quarters of them in Romania, where a national measles epidemic was declared in December 2023.

For the original SARS-CoV-2 strain with R0 around 3, HIT was approximately 67%. The public debates of 2020 and early 2021 about achieving “natural herd immunity”, most prominently around the Great Barrington Declaration, were being conducted against this estimate. By the time Delta was dominant, its R0 was estimated at about 5, pushing HIT to around 80%. With Omicron’s mean R0 of around 9.5, the threshold was approaching 90%. Natural herd immunity at that level, achievable only through mass infection in a population with uneven prior immunity, implies a death toll that renders the strategy incoherent on its own terms.

Why smallpox could be eradicated and COVID cannot

Smallpox remains the only human disease ever eradicated, through a deliberate global vaccination campaign. Its R0, estimated at roughly 3.5 to 6 in unvaccinated populations, implied a HIT of roughly 70–83%, achievable with coordination. But the decisive advantages lay in the disease itself. Smallpox has no animal reservoir; once eliminated from human populations, it cannot re-emerge from a non-human host. Its visible presentation, a distinctive rash that appeared before or together with peak infectiousness, made cases identifiable without laboratory testing and enabled ring vaccination: targeting transmission networks rather than requiring universal coverage. The last naturally occurring case was Ali Maow Maalin in Somalia in 1977. The WHO declared eradication in 1980. COVID, by contrast, has animal reservoirs, evolves at a rate that continuously generates immune-evasive variants, and reaches peak infectiousness before symptom onset. Eradicating COVID worldwide was never a realistic prospect once it established sustained human transmission.

The line between elimination and endemicity is blurrier than the textbook suggests. A disease can linger in a long-lived, low-prevalence state even below the classical epidemic threshold, when a trickle of undetected imported infections keeps reseeding local outbreaks; a model of that mechanism reproduces the pattern in England’s COVID-19 data. Influenza A cannot be eliminated because it maintains animal reservoirs, drifts antigenically from season to season and occasionally shifts into an entirely new subtype.

The literacy problem

During COVID, epidemiologists were working all of this out in published papers. Three failures of public communication trace to the gap between what the math showed and what the public was equipped to read.

The first: “flattening the curve” was widely heard as preventing illness. What it meant, as anyone running the SIR final-size equation could see, was spreading much of the same infection burden over time so that simultaneous hospitalizations would not overwhelm health system capacity, which is a different goal. In the basic SIR framework, temporary behavioral interventions imposed and relaxed as pressure eases mostly change the curve’s shape and timing; they shrink the area under it only by trimming the overshoot, and how much depends on when they start and how long and hard they run. Sustained interventions that hold transmission down until a vaccine arrives can cut total infections far more, if behavior change lasts long enough or the vaccine comes fast enough. In much of the public conversation, the message collapsed into a simpler claim: suppress early, prevent entirely. A population carrying that understanding wasn’t equipped to process why restrictions and rising case counts coexisted through multiple waves, or why the end of each wave wasn’t a victory. For a population running temporary interventions against a pathogen with R0 above 1, while most people were still susceptible, the mathematical expectation was always that the epidemic would resume.

The second: herd immunity was treated as a threshold that expert committees tracked, though anyone with a publicly available R0 estimate and a calculator could derive it. For the original strain, with R0 around 3, the simple model puts HIT near 67%. Reaching that threshold through infection alone in a country of 50 million means about 33.5 million infections. One pre-vaccine meta-analysis estimated the pooled COVID infection fatality rate at about 0.68%, implying roughly 230,000 deaths just to reach the threshold, before the overshoot adds more. Epidemiologists did this kind of calculation in journals, but it rarely framed the public debate over the Great Barrington Declaration. The result was a population that couldn’t evaluate the real cost of the approach being proposed.

The third: variants were presented as biological surprises. Alpha, Delta and Omicron were each introduced as an unexpected development requiring updated guidance. The three Ts framework reads the rise of more transmissible variants differently: with a huge susceptible pool and transmission unchecked across much of the world, selection favoring transmissibility was a conditional but predictable outcome of the environment the epidemic itself was generating. That conditional forecast rarely shaped how new variants were explained to the public.

Without epidemiological literacy, every consequential decision about schools, masks, vaccines, lockdowns or the acceptable cost of “natural” herd immunity rests on the officials who understand the parameters, and on what they choose to translate into public language. With it, people can check the arithmetic and hold those decisions to account.

The same measles virus can show an R0 of 18 or barely 5, partly because of how the people it moves through are arranged. A public that can read that number can argue about the arrangement.

Related articles

Further reading

As an Amazon Associate, Eikleaf earns from qualifying purchases. The book links below are affiliate links: if you buy through them, we may earn a small commission at no extra cost to you.

Recommended videos

Cite this article
Ulfur Atli. “The science of infectious disease: why pandemics follow predictable patterns.” Eikleaf, 7 May 2026, updated 2 November 2026. https://www.eikleaf.com/the-science-of-infectious-disease-why-pandemics-follow-predictable-patterns/

Gen AI Disclaimer

Some contents of this page were generated and/or edited with the help of a Generative AI.

Media

Colorized scanning electron micrograph of a cell (purple) infected with the Omicron strain of SARS-CoV-2 virus particles (green), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID – Wikipedia

Key Sources and References

Kermack WO, McKendrick AG. A Contribution to the Mathematical Theory of Epidemics. Proceedings of the Royal Society A. 1927;115(772):700-721. https://doi.org/10.1098/rspa.1927.0118

Delamater PL, Street EJ, Leslie TF, Yang YT, Jacobsen KH. Complexity of the Basic Reproduction Number (R0). Emerging Infectious Diseases. 2019;25(1):1-4. https://doi.org/10.3201/eid2501.171901

Guerra FM, Bolotin S, Lim G, Heffernan J, Deeks SL, Li Y, Crowcroft NS. The basic reproduction number (R0) of measles: a systematic review. Lancet Infectious Diseases. 2017;17(12):e420-e428. https://doi.org/10.1016/S1473-3099(17)30307-9

Mills CE, Robins JM, Lipsitch M. Transmissibility of 1918 pandemic influenza. Nature. 2004;432(7019):904-906. https://doi.org/10.1038/nature03063

Taubenberger JK, Morens DM. 1918 Influenza: the Mother of All Pandemics. Emerging Infectious Diseases. 2006;12(1):15-22. https://doi.org/10.3201/eid1201.050979

Centers for Disease Control and Prevention. 1918 Pandemic (H1N1 virus). CDC Pandemic Influenza historical resources (archived). https://archive.cdc.gov/www_cdc_gov/flu/pandemic-resources/1918-pandemic-h1n1.html

Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. Journal of Infectious Diseases. 1998;178(1):53-60. https://doi.org/10.1086/515616

Gagnon A, Miller MS, Hallman SA, Bourbeau R, Herring DA, Earn DJD, Madrenas J. Age-Specific Mortality During the 1918 Influenza Pandemic: Unravelling the Mystery of High Young Adult Mortality. PLoS ONE. 2013;8(8):e69586. https://doi.org/10.1371/journal.pone.0069586

Cilek L, Chowell G, Ramiro Fariñas D. Age-Specific Excess Mortality Patterns During the 1918–1920 Influenza Pandemic in Madrid, Spain. American Journal of Epidemiology. 2018;187(12):2511-2523. https://doi.org/10.1093/aje/kwy171 · https://pmc.ncbi.nlm.nih.gov/articles/PMC6454514/

Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature. BMC Infectious Diseases. 2014;14:480. https://doi.org/10.1186/1471-2334-14-480

Centers for Disease Control and Prevention. 1957–1958 Pandemic (H2N2 virus) and 1968 Pandemic (H3N2 virus). CDC Pandemic Influenza historical resources (archived). https://archive.cdc.gov/www_cdc_gov/flu/pandemic-resources/1957-1958-pandemic.html · https://archive.cdc.gov/www_cdc_gov/flu/pandemic-resources/1968-pandemic.html

Viboud C, Grais RF, Lafont BAP, Miller MA, Simonsen L. Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. Journal of Infectious Diseases. 2005;192(2):233-248. https://doi.org/10.1086/431150

Jackson C, Vynnycky E, Mangtani P. Estimates of the Transmissibility of the 1968 (Hong Kong) Influenza Pandemic: Evidence of Increased Transmissibility Between Successive Waves. American Journal of Epidemiology. 2010;171(4):465-478. https://doi.org/10.1093/aje/kwp394

Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. Journal of Travel Medicine. 2020;27(2):taaa021. https://doi.org/10.1093/jtm/taaa021

Gandhi M, Yokoe DS, Havlir DV. Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19. New England Journal of Medicine. 2020;382(22):2158-2160. https://doi.org/10.1056/NEJMe2009758

Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, Taylor J, Spicer K, Bardossy AC, Oakley LP, Tanwar S, Dyal JW, Harney J, Chisty Z, Bell JM, Methner M, Paul P, Carlson CM, McLaughlin HP, Thornburg N, Tong S, Tamin A, Tao Y, Uehara A, Harcourt J, Clark S, Brostrom-Smith C, Page LC, Kay M, Lewis J, Montgomery P, Stone ND, Clark TA, Honein MA, Duchin JS, Jernigan JA. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. New England Journal of Medicine. 2020;382(22):2081-2090. https://doi.org/10.1056/NEJMoa2008457

Visher E, Evensen C, Guth S, Lai E, Norfolk M, Rozins C, Sokolov NA, Sui M, Boots M. The three Ts of virulence evolution during zoonotic emergence. Proceedings of the Royal Society B: Biological Sciences. 2021;288(1956):20210900. https://doi.org/10.1098/rspb.2021.0900

Acevedo MA, Dillemuth FP, Flick AJ, Faldyn MJ, Elderd BD. Virulence-driven trade-offs in disease transmission: A meta-analysis. Evolution. 2019;73(4):636-647. https://doi.org/10.1111/evo.13692

Liu Y, Rocklöv J. The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus. Journal of Travel Medicine. 2021;28(7):taab124. https://doi.org/10.1093/jtm/taab124

Liu Y, Rocklöv J. The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta. Journal of Travel Medicine. 2022;29(3):taac037. https://doi.org/10.1093/jtm/taac037

European Centre for Disease Prevention and Control. Measles on the rise in the EU/EEA. Threat Assessment Brief. February 2024. https://www.ecdc.europa.eu/sites/default/files/documents/measles-eu-threat-assessment-brief-february-2024.pdf

Gani R, Leach S. Transmission potential of smallpox in contemporary populations. Nature. 2001;414(6865):748-751. https://doi.org/10.1038/414748a

Aguilar J, Arregui García B, Toral R, Meloni S, Ramasco JJ. Endemic infectious states below the epidemic threshold and beyond herd immunity. Communications Physics. 2023;6:187. https://doi.org/10.1038/s42005-023-01302-0

Bliman PA, Duprez M. How best can finite-time social distancing reduce epidemic final size? Journal of Theoretical Biology. 2021;511:110557. https://doi.org/10.1016/j.jtbi.2020.110557

Meyerowitz-Katz G, Merone L. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates. International Journal of Infectious Diseases. 2020;101:138-148. https://doi.org/10.1016/j.ijid.2020.09.1464

ADVERTISEMENT